What are the top 3 endocrine complications in beta-thalassemia intermedia?

  • Karimi M & al.
  • Endocrine
  • 18 Dec 2019

  • International Clinical Digest
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Osteopenia/osteoporosis, hypogonadism, and primary hypothyroidism are the most common endocrine complications in patients with beta-thalassemia intermedia (β-TI).

Why this matters

  • Data on the prevalence and type of endocrine disorders are limited in this patient group.

Key results

  • The most prevalent complications were osteopenia/osteoporosis (26.2%), hypogonadism (9.8%), and primary hypothyroidism (5.2%).
  • Age >35 years was associated with osteoporosis (OR, 7.870; P<.001 hypogonadism and noninsulin-dependent diabetes mellitus>
  • Splenectomy was associated with osteoporosis (OR, 1.736; P=.045).
  • Hydroxyurea was associated with reduced risk for noninsulin-dependent diabetes mellitus (OR, 0.259; P=.034).

Study design

  • 522 patients with β-TI were analyzed for endocrine disorders and associated risk factors.
  • Funding: None disclosed.

Limitations

  • A cross-sectional study with a heterogeneous patient population.